Beijing Changping Science and Technology Park Development Group

Name

Beijing Changping Science and Technology Park Development Group

Legal name

北京昌平科技园发展有限公司

Website

https://bc-tid.com

Company type

Private

Founded year

2015

Operating status

Operating

Ownership category

akta.pro rank

Product category

Science and Technology Park Development and Operation

NAICS

Management of Companies and Enterprises (5511)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Industrial Park Owners Association Management (BPAJAHAH)

akta.pro secondary industries

Public Health & Reference Lab LIMS (HLACAMAF), Laboratory Information Management Systems (LIMS) (HLAGAJAA), Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)

Keywords

• Industrial park management
• Medical device CMO
• Venture capital funds
• Smart park services
• Biomedical incubator

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Others, Marketing or Sales, Technology or R&D

Revenue model

1. Industrial Services (产业服务): The group provides industrial services including policy advisory, HR consulting, clean-room facility setup, digitization/transformation services, property management, and FA (financial advisory) to enterprises in its parks. Revenue is earned through service fees for these professional service offerings.
2. Asset Management (资产管理): The group manages physical real estate assets across multiple park zones in Changping District (Huilongguan, Tiantongyuan, Science Park areas, Future Science City, etc.), generating rental income and asset appreciation from office, commercial, and industrial properties.
3. Technology Finance / Fund Management (科技金融): Through its technology finance platform, the group manages mother funds (母基金), direct investment funds (直投基金), and merge & acquisition funds, earning management fees and performance fees (carry) from fund operations. The group has also invested directly in over 40 companies.
4. Medical Device CMO Platform (医疗器械CMO平台): 昌科华光 (Changke Huaguang) operates as a state-controlled Contract Manufacturing Organization (CMO) under the medical device Marketing Authorization Holder (MAH) system, providing commissioned design development, manufacturing of medical device samples and products, and post-certification production services for medical device registrants.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Beijing Changping Science and Technology Park Development Group operates an integrated industrial ecosystem platform combining (1) Asset Management of multiple specialized science parks across Changping District, (2) Technology Finance through parent funds, direct investment funds and post-investment services, and (3) full-stack Industry Services including a state-controlled medical device CMO platform and a proprietary smart park management platform. The group serves 800+ enterprises across biomedical, advanced manufacturing, digital economy, and life sciences sectors, generating revenue from rental income, fund management and performance fees, professional service fees, and contract manufacturing.

Product overview

Beijing Changping Science and Technology Park Development Group (昌发展集团) operates as a one-stop industrial ecosystem platform centered on three core business lines: Asset Management (multi-zone park portfolio covering precision medicine, intelligent manufacturing, synthetic biology, medical devices, applied optics, and AI), Technology Finance (科技产业母基金群, 知衡直投基金, and the 北京未来科学城先进能源和智能制造产业股权投资基金), and Industry Services (产业服务 comprising general services — policy, talent, property, business, digital transformation — plus specialized platforms including the medical device CMO platform 昌科华光, the smart park management platform 昌智汇, and sector-specific innovation centers such as 国际精准医学创新中心/加速中心, 合成生物制造转化加速中心, Champion Bio国际医疗器械城, M+医&美创新中心, 生命谷健康云创新中心, 昌平生命谷远毅数字医疗孵化器, and 新元科技园). The group also operates the 回+双创社区 innovation community and manages AI acceleration facilities (昌发展AI加速中心北区). The portfolio forms an integrated ecosystem supporting enterprises across all growth stages — from incubation and R&D through pilot-scale production to commercialization — within the Beijing Changping District science and technology corridor.

Differentiator

Problem solved

Functional benefit

Products and services

• Changzhi Hui (昌智汇) Smart Park Service Platform Proprietary smart park management platform providing enterprises with integrated asset management, intelligent access control, smart office, and intelligent operations management built on cloud, AI, big data, IoT and mobile technologies. Tenants can book renovations, submit maintenance requests, reserve meeting rooms, and pay smart parking fees online.
• Changke Huaguang (昌科华光) Medical Device CMO Platform Medical device Contract Manufacturing Organization platform providing full-chain services for medical device MAH holders from early-stage design and development to commercial-scale manufacturing. Offers commissioned R&D, commissioned production, and sales services for sterile products, active devices, and in vitro diagnostics. Holds Beijing's first entrusted production medical device filing certificate and is ISO 9001 and ISO 13485 certified.
• Tech Finance Fund Investment Platform (科技金融) A fund investment platform covering parent fund of funds, direct investment funds, merger & acquisition funds, and multi-level post-investment value-added services. Includes the Tech Industry Fund of Funds (科技产业母基金群), direct investment platforms, and comprehensive financial services supporting the innovation and entrepreneurship ecosystem.
• Asset Management — Multi-zone Park Portfolio (资产管理) Physical asset management across multiple innovation parks and commercial properties in Changping District including Huilongguan, Tiantongyuan, Science Park areas, Future Science City, and Hui+ Xiang Xiang. Manages property assets to maximize value and serve industries at various development stages.
• Industry Services One-stop Service Platform (产业服务) A comprehensive one-stop service platform providing foundational industry promotion services (policy, talent, property, business, purification decoration, digital) and specialized industry services across biomedical, advanced manufacturing, and digital economy sectors.
• Zhiheng Direct Investment Fund (知衡直投基金) Direct investment fund with a scale of RMB 291.6 million, focusing on biomedical, medical devices, and healthcare services. Has invested in 19 projects including Pinchi Medical, Huahui Anjian, Tupai Medical, and Yanming Biosciences.
• International Precision Medicine Innovation/Acceleration Center (国际精准医学创新中心/加速中心) A precision medicine innovation and acceleration platform focusing on cell and gene therapy, AI-driven drug discovery, AI-assisted medical care, GMP pilot-scale production, and TCR-T/CAR-NK/iPSC clinical translation. Collaborates with Danaher for scientific solutions.
• Synthetic Biology Manufacturing Transformation Acceleration Center (合成生物制造转化加速中心) A key public technology platform for synthetic biology manufacturing, co-built with Danaher Group (Fortune 500) and Chinese Academy of Sciences Institute of Process Engineering. Provides high-throughput strain construction, process optimization, pilot-scale validation, and academic exchange services.
• Champion Bio International Medical Device City (国际医疗器械城) A high-end medical device industrial cluster targeting globally influential innovations, covering brain-like intelligence, implant devices, high-end diagnostic equipment, biomedical materials, aesthetic medicine devices, and IVD. Approximately 1.2 million sqm planned area.
• Life Valley International Precision Medicine Industrial Park (生命谷国际精准医学产业园) A life science and brain-computer interface industry cluster designated as the first Zhongguancun (Changping) Brain Science and Brain-Computer Interface Industry Agglomeration Area and Industrial Park. Flagship project of Zhongguancun Life Science Park Phase III, jointly created with Kangqiao Healthcare.
• Xinyuan Science Park (新元科技园) — Applied Optics Specialty Industrial Park An intelligent manufacturing specialty industrial park within the Zhongguancun Changping Science Park, targeting applied optics and intelligent manufacturing. Industry concentration approximately 80%, with 80+ national high-tech enterprises and 5 national 'little giant' specialized enterprises. Awarded 2025 Zhongguancun Featured Industrial Park designation.
• Life Valley Health Cloud Innovation Center (生命谷健康云创新中心) AI-driven park innovation platform jointly built with Huawei, providing drug R&D cloud platform, EI intelligent body, GXP-compliant MES, SCADA, WMS, QMS, LIMS, CTMS, and pharma data/knowledge base solutions across the drug development lifecycle.
• Changping Life Valley Yuanyi Digital Medical Incubator (昌平生命谷远毅数字医疗孵化器) Jointly established by Changfazhan Group, Zhongguancun Life Science Park, and Yuanyou Capital, focusing on AI medical care, medical robots, genomics, digital therapeutics, and InsurTech. Builds a global digital medical industry ecosystem.
• M+ Medical Aesthetics Innovation Center (M+医美创新中心) Medical aesthetics technology-driven innovation center with approximately 10,000 sqm, anchored by Aimeikong (爱美客) R&D headquarters, targeting domestic substitution of high-end energy-based aesthetic devices, regenerative materials, and synthetic biology-based biological ingredients.
• High-end Electronics Manufacturing Service (高端电子产品制造服务) One-stop high-end electronics manufacturing service platform jointly built with Wanlong Jingyi (万龙精益), integrating flexible intelligent manufacturing, industrial internet services, and IC industry acceleration.
• Changke Medical Testing Laboratory (昌科医学检验实验室) Third-party medical testing laboratory co-built with Huizhen Bio, offering sequencing (NGS, Sanger, qPCR), mass spectrometry, and single-cell sequencing for precision medication guidance in cancer treatment.

Quantifiable outcome

• 800+ enterprises served across 10+ industries
• +4 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Beijing Information Science and Technology University (北京信息科技大学)minorStrategic or Co-development Partner · 26 March 2026The Group's New Yuan Science Park (新元科技园) signed a cooperation agreement with Beijing Information Science and Technology University to jointly establish a graduate student practice and innovation base. The partnership adopts a dual-mentor system and focuses on applied optics and intelligent manufacturing research collaboration and talent development.
• Beijing Normal University Technology Group (北京师范大学科技集团)minorStrategic or Co-development Partner · 27 July 2019The Group co-hosted the 6th 民建昌平工委企业家沙龙活动 with Beijing Normal University Technology Group at Jidian Center (奇点中心), exploring school-city integration, industry-academia-research collaboration, and cooperation models for technology transfer.
• Danaher Group (丹纳赫集团)coreStrategic or Co-development PartnerThe Group partnered with Danaher, a Fortune 500 life science company, and the Chinese Academy of Sciences Institute of Process Engineering (中国科学院过程工程所) to co-establish the Synthetic Biology Manufacturing Transformation Acceleration Center (合成生物制造转化加速中心). Danaher provides laboratory automation technologies (including SCIEX mass spectrometry detection platforms) as part of the platform's core infrastructure. The center serves as a joint innovation hub for synthetic biology R&D, pilot production, and academic exchange.
• Kangqiao Healthcare (康桥医疗健康产业设施平台)coreStrategic or Co-development PartnerThe Group partnered with Kangqiao Healthcare to jointly develop the Life Valley International Precision Medical Industrial Park (昌平生命谷国际精准医学产业园), which serves as the flagship project of Zhongguancun Life Science Park Phase III. The partnership brings together the Group's park development capabilities with Kangqiao's healthcare facility platform expertise.
• European China Enterprise Association (欧中企业联合会)coreStrategic or Co-development PartnerPartnered to establish the China-EU Innovation Industrial Park (中欧创新产业园), officially launched at the 2026 Zhongguancun Forum. The park is positioned to connect European and Chinese innovation resources, creating a 'European technology + Chinese market' and 'Chinese innovation + European resources' model in biomedical and advanced manufacturing sectors.
• Huitianyang (回天有我 Community Network)minorStrategic or Co-development Partner回+ 双创社区 (Hui+ Innovation Community), operated by the Group, partners with community organizations and local government to provide innovation and entrepreneurship services to the Huitian (回天) area, integrating community needs with startup resources.
• China Medical Instruments Corporation (中国医疗集团)minorStrategic or Co-development PartnerThe Group partnered with China Medical Instruments Corporation and other organizations to establish the 'HIBIO Family' industry event series, hosting cross-border biotech regulatory and BD seminars featuring expert speakers from top pharma companies and law firms.
• Zhongguancun Changping Park Management CommitteecoreOthers
• Future Science城 Management CommitteecoreOthers

Scale indicators7 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• Wuxi Industrial Development Group: Wuxi municipal SOE industrial platform combining park management, industrial investment funds, and biomedical/life sciences incubation (Wuxi Biotech). Comparable for SOE platform + biomedical focus + integrated fund + park model.
• Hangzhou Hi-Tech Industrial Development: Municipal-level platform operating Hangzhou Hi-Tech Zone (Zhejiang) parks and industrial services targeting biotech, advanced manufacturing, and digital economy. Comparable for government-backed science park + biomedical cluster focus.
• Shanghai Lingang Economic Development Group: Shanghai municipal SOE industrial park developer operating Lingang Free Trade Zone and specialty industrial parks combining real estate, services, and investment functions. Comparable for SOE-led integrated park ecosystem model.
• Zhongguancun Development Group: Beijing municipal government-backed parent-level technology park and industrial ecosystem platform operating Zhongguancun parks, funds, and services. Most directly comparable peer as the Group is a district-level sub-platform within the same government-controlled ecosystem.
• Tus-Holdings: Major Chinese science park operator and technology investment group with Tsinghua University heritage, operating TusPark network plus TusStar incubators and direct investment platforms. Highly comparable on university-linked park + fund + incubation integration.
• Beijing E-Town International Investment Development: Beijing municipal SOE operating Beijing Economic-Technological Development Area (BDA/Yizhuang), an integrated industrial park focused on advanced manufacturing and biotech. Closest peer within Beijing competing for similar tenants and policy attention.
• China-Singapore Suzhou Industrial Park Development Group (CSSD): Joint government-backed industrial park developer and operator combining real estate, industrial services, and investment activities. Comparable for the public-private mixed ownership park development model serving industrial tenants.
• Zhangjiang Hi-Tech Park Development Co. Shanghai-listed science park developer and operator combining property, venture capital (Zhangjiang Hi-Tech Venture), and incubation services in Shanghai's Zhangjiang High-Tech Park. Closest listed comparable for the integrated park + fund + services model.

Emerging players

• Alexandria Real Estate Equities: US-listed REIT specializing in life science and biotech innovation campuses combining real estate, venture funding, and tenant services. Indirect global comparable for the integrated biomedical park + investment model at significant scale.

Broad incumbents

• China Fortune Land Development: Large industrial new-city developer combining real estate with industrial introduction services. Broader incumbent in industrial park development but serves primarily greenfield industrial new cities rather than urban science parks.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beijing Changping Science and Technology Park Development Group